tiprankstipranks
Trending News
More News >
Movano (MOVE)
NASDAQ:MOVE
US Market

Movano (MOVE) AI Stock Analysis

Compare
135 Followers

Top Page

MOVE

Movano

(NASDAQ:MOVE)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 5.2)
Rating:40Underperform
Price Target:
$7.50
▲(7.45% Upside)
The score is driven primarily by very weak financial performance (large losses, negative gross margin, significant cash burn, and negative equity). Technicals are also soft (negative MACD and below key moving averages), while valuation is not meaningfully supportive due to negative earnings and no dividend. Corporate events add risk due to Nasdaq compliance concerns and potential dilution from expanded share authorization.
Positive Factors
No Debt
Having no debt provides Movano with greater financial flexibility and reduces financial risk, allowing the company to focus on growth and innovation without the burden of interest payments.
Innovative Product Offering
Movano's focus on innovative wearable healthcare devices positions it well in the growing health tech industry, offering potential for long-term market penetration and consumer adoption.
Strategic Revenue Model
Movano's diversified revenue streams through direct sales, partnerships, and potential subscriptions enhance its ability to capture various market segments and stabilize revenue over time.
Negative Factors
Negative Profitability
Negative profitability highlights operational inefficiencies and challenges in cost management, which could hinder Movano's ability to invest in growth and innovation.
Cash Flow Issues
Persistent negative cash flow indicates that Movano's operations are not generating sufficient cash, potentially limiting its ability to fund new projects or respond to market opportunities.
Nasdaq Compliance Challenges
Non-compliance with Nasdaq listing requirements poses a risk to Movano's market presence and investor confidence, potentially affecting its ability to raise capital and maintain stock liquidity.

Movano (MOVE) vs. SPDR S&P 500 ETF (SPY)

Movano Business Overview & Revenue Model

Company DescriptionMovano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
How the Company Makes MoneyMovano makes money primarily through the sale of its wearable healthcare devices. The company's revenue model revolves around direct sales to consumers, partnerships with healthcare providers, and potentially through subscription-based services that offer enhanced features or data analytics. Movano may also explore partnerships with insurance companies or corporate wellness programs, leveraging its technology to offer value-added services. Additionally, Movano could generate revenue from licensing its technology to other companies in the healthcare and technology sectors. These revenue streams are supported by ongoing research and development, aimed at expanding the capabilities and market reach of its products.

Movano Financial Statement Overview

Summary
Movano is currently facing financial headwinds, with substantial operational inefficiencies and negative profitability metrics. The balance sheet is stable with no debt, but limited equity and assets constrain financial flexibility. Cash flow issues persist, emphasizing the need for strategic focus on improving operational efficiency and cash management to enhance financial health.
Income Statement
The company's income statement indicates a challenging financial position. Gross profit margin is significantly negative, reflecting a higher cost of goods sold than revenue. The net profit margin is also negative, indicating no profitability. Revenue growth is positive due to the recent start of revenue generation, but EBIT and EBITDA margins remain deeply negative, showing operational inefficiencies.
Balance Sheet
The balance sheet reveals a moderate level of stability. There is no debt, which is a positive sign, but low stockholders' equity indicates limited financial resilience. The equity ratio is decent, suggesting that the company is not overly leveraged, but the small asset base limits growth potential.
Cash Flow
Cash flow analysis depicts a concerning trend with significant negative free cash flow, indicating cash outflows exceed inflows. Operating cash flow is also negative, suggesting operational activities are not generating cash. The free cash flow to net income ratio is not applicable due to zero net income, highlighting ongoing cash management challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue500.00K1.01M0.000.000.000.00
Gross Profit-1.35M-1.99M-158.00K-134.00K-74.00K-13.00K
EBITDA-15.45M-24.06M-29.13M-30.20M-20.82M-12.01M
Net Income-17.05M-23.73M-29.28M-30.20M-22.58M-14.04M
Balance Sheet
Total Assets5.56M11.32M9.42M13.24M36.27M7.08M
Cash, Cash Equivalents and Short-Term Investments2.00M7.90M6.12M10.76M33.60M5.71M
Total Debt0.00186.00K217.00K426.00K0.0011.69M
Total Liabilities7.26M3.96M5.97M5.33M3.54M15.14M
Stockholders Equity-1.70M7.36M3.45M7.92M32.73M-8.06M
Cash Flow
Free Cash Flow-13.57M-22.54M-26.24M-25.01M-16.75M-10.67M
Operating Cash Flow-13.56M-22.53M-26.18M-24.90M-16.18M-10.67M
Investing Cash Flow-5.00K-8.00K-64.00K15.72M-16.70M0.00
Financing Cash Flow4.30M24.32M21.60M2.26M44.85M12.09M

Movano Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.98
Price Trends
50DMA
8.64
Negative
100DMA
7.84
Negative
200DMA
7.94
Negative
Market Momentum
MACD
-0.36
Positive
RSI
40.51
Neutral
STOCH
12.27
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MOVE, the sentiment is Negative. The current price of 6.98 is below the 20-day moving average (MA) of 8.00, below the 50-day MA of 8.64, and below the 200-day MA of 7.94, indicating a bearish trend. The MACD of -0.36 indicates Positive momentum. The RSI at 40.51 is Neutral, neither overbought nor oversold. The STOCH value of 12.27 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MOVE.

Movano Risk Analysis

Movano disclosed 38 risk factors in its most recent earnings report. Movano reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Movano Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
44
Neutral
$1.20M-0.02-126.20%97.70%
43
Neutral
$3.41M-0.15-178.18%-49.63%82.22%
40
Underperform
$6.51M-0.30-398.78%-44.57%55.97%
40
Underperform
$3.54M-0.10-352.39%63.87%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MOVE
Movano
7.05
-49.65
-87.57%
BBLG
Bone Biologics
1.63
-4.26
-72.33%
BJDX
Bluejay Diagnostics
0.66
-2.70
-80.42%
TIVC
Tivic Health Systems
1.27
-3.23
-71.78%
AMIX
Autonomix Medical, Inc.
0.50
-2.25
-81.82%

Movano Corporate Events

Private Placements and FinancingRegulatory Filings and ComplianceShareholder Meetings
Movano Stockholders Approve Key Amendments and Initiatives
Positive
Dec 17, 2025

On December 16, 2025, Movano Inc.’s stockholders approved key amendments and initiatives during a Special Meeting, including Amendment No. 3 to its 2019 Omnibus Incentive Plan, enhancing the ability to further incentivize employees. Additionally, stockholders endorsed increasing the company’s authorized shares of common stock from 500 million to 2.5 billion, paving the way for potential expansion and fundraising opportunities, while also aligning with Nasdaq compliance for a share issuance agreement.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

M&A TransactionsPrivate Placements and Financing
Movano Announces Merger with Corvex, Inc.
Neutral
Nov 10, 2025

On November 6, 2025, Movano Inc. entered into a merger agreement with Corvex, Inc., where Corvex will become a wholly-owned subsidiary of Movano. The merger, expected to close in the first quarter of 2026, aims to position the combined company to capture demand for AI infrastructure at scale. Corvex stockholders will own approximately 96.2% of the combined entity, with Movano stockholders owning 3.8%. The merger includes significant equity financing, with Movano raising $3 million and Corvex raising $37.1 million. The merger will also see Movano’s name change to Corvex, Inc., and its headquarters move to Arlington, Virginia.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

Private Placements and Financing
Movano Amends Loan Agreement with Evie Holdings
Neutral
Nov 7, 2025

Movano announced an amendment to its existing Loan Agreement with Evie Holdings LLC, originally dated August 6, 2025. The amendment, entered on November 3, 2025, extends the maturity date of the loan to November 5, 2025, providing the company with additional time to manage its financial obligations.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025